Addressing Antibiotic Resistance in Minnesota's Animal Health: A Vital Stewardship Priority
Minnesota faces a critical challenge in the realm of antibiotic stewardship – the rising prevalence of antibiotic-resistant bacteria in animal populations. Campylobacter and non-typhoidal Salmonella, responsible for a significant portion of foodborne illnesses, are increasingly demonstrating resistance to multiple antibiotic classes.
The emergence of the carbapenem-resistant Enterobacterales (CRE) superbug in a Minnesota veterinary setting in 2022 raised alarms, as further investigation uncovered additional CRE-positive dogs in multiple locations. To safeguard both animal and human health, it is imperative that we equip veterinary professionals with the knowledge and tools to prevent, detect, and respond to such outbreaks.
The Minnesota One Health Antibiotic Stewardship Collaborative plays a crucial role in providing a collaborative platform for veterinary and public health experts to address this pressing issue, reinforcing the importance of responsible antibiotic use in the animal health sector.
Visit the Minnesota One Health Antibiotic Stewardship Collaborative webpage for more information and resources.
FDA Framework for Collecting Antimicrobial Use Data
The Food and Drug Administration (FDA) is taking significant steps towards promoting responsible antibiotic use in animals. One of the recent developments is the proposal for a framework to collect and analyze antimicrobial use data from food-producing animals through a public-private partnership. This initiative is a crucial move in the direction of ensuring the responsible use of antibiotics in the animal agriculture industry.
Key highlights:
- FDA is inviting public comments on the report, outlining the framework.
- The framework aims to gather data on antibiotic usage in food-producing animals.
- This initiative promotes transparency and data-driven decision-making in animal health.
Learn more:
FDA Five-Year Plan 2024-2028: Supporting Antimicrobial Stewardship in Veterinary Settings
The FDA's Five-Year Plan, titled "Supporting Antimicrobial Stewardship in Veterinary Settings, Goals for Fiscal Years 2024-2028," is a roadmap to promote responsible antibiotic use in veterinary settings. This plan aligns with the FDA's three main veterinary stewardship goals and kicked off on Oct. 1, 2023.
Key goals:
- Aligning antimicrobial drug product use with the principles of antimicrobial stewardship.
- Fostering stewardship of antimicrobials in veterinary settings.
- Enhancing monitoring of antimicrobial resistance and antimicrobial drug use in animals.
Learn more:
Lori Nicholson and Mr. Beebs
Pet owner and advocate for companion animal health
|
|
 |
What are your experiences with antibiotics?
Antibiotics are often prescribed by veterinarians without the benefit of a culture and sensitivity report [laboratory test to determine what type of bacteria is causing the infection and what antibiotics would work best to treat the infection]. Sometimes that approach works but when it doesn’t, the situation becomes exponentially more dangerous.
What are your experiences with antibiotic resistance?
My dog, Mr. Beebs, had orthopedic surgery and was sent home with broad-spectrum antibiotics. Two weeks later, a fistula opened in his leg. He was re-hospitalized and given another round of the same antibiotics. Weeks later, the culture and sensitivity report came back and the organism, Enterobacter Cloacae, was resistant to all the standard antibiotics except the carbapenem drug imipenem/cilastatin, a last-line antibiotic.
Visit our Stories of Antibiotic Use and Resistance webpage for more on this and other stories.
Antimicrobial Resistance and Stewardship Initiative | College of Veterinary Medicine - University of Minnesota
Featured webinar:
Short videos for veterinary professionals and students:
|
